Article

Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study.

Departments of Respiratory Medicine, Surgery, and Obstetrics and Gynecology, Kuopio University Hospital, Research Institute of Public Health, University of Kuopio, Kuopio, Finland.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.04). 04/1999; 159(4 Pt 1):1179-85.
Source: PubMed

ABSTRACT It is not known whether asthma constitutes a risk factor for osteoporosis or what the impact is of inhaled corticosteroids on bone mineral density (BMD). The study population (n = 3,222) was a random stratified sample from the Kuopio Osteoporosis Study, which included all women 47 to 56 yr of age residing in Kuopio Province, Eastern Finland. Spinal and femoral BMDs were measured using dual-energy X-ray absorptiometry. The BMD values of 119 asthmatics were cross-sectionally compared with those of 3,103 nonasthmatics. Of the 119 asthmatic women, 28 had not used corticosteroids, 65 had used oral corticosteroids, and 26 had used only inhaled corticosteroids. The asthmatics with no hormone replacement therapy (HRT) (n = 83) had lower mean spinal and femoral BMD value than did the corresponding nonasthmatics (spinal BMD, 1.083 +/- 0.150 [SD] versus 1.128 +/- 0.160 g/cm2, p < 0.05; femoral BMD, 0.894 +/- 0.112 [SD] versus 0.929 +/- 0.128 g/cm2, p < 0.05). Although BMDs were not significantly decreased in the asthmatics who had used inhaled corticosteroids, the duration of use correlated negatively with spinal BMD and was also associated with spinal BMD in multiple regression analysis. In perimenopausal women, asthma is associated with decreased bone density. This may be due to the corticosteroids rather than to the disease itself. However, HRT appears to be protective against bone loss also in asthmatics.

0 Bookmarks
 · 
43 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The reactivity of bulky tris(trimethylsilyl)methyl group substituted aluminum trialkyl [(Me3Si)3CAlMe2·THF] (1) with a series of substituted benzoic acid derivatives has been investigated. An equimolar reaction of 4-methyl benzoic acid or 4-tert-butyl benzoic acid with 1 in toluene at 50°C leads to the formation of cyclic dimeric aluminum carboxylates [(Me3Si)3CAl(Me)(μ-O2CC6H4R)]2 (R=Me 2; tBu 3). Reaction of 3,5-di-iso-propylsalicylic acid (H2dipsa) with 1 leads to the exclusive isolation of a trimeric organoaluminum carboxylate [(Me3Si)3CAl(μ-dipsa)]3 (4), in which each aluminum is bound to two carboxylates, a phenoxide, and an alkyl group and produce a 12-membered macrocycle. Deliberate, but controlled, introduction of water in the form of 3,5-di-tert-butyl salicylic acid monohydrate (H2dtbsa·H2O) in the reaction with 1 in toluene leads to the isolation of carboxylate [(Me3Si)3CAl(μ-O)(μ-Hdtbsa)}2] (5) with a bicyclic structure. Compound 5 represents a rare example of an organoalumoxane carboxylate that simultaneously possesses alkyl, oxo, and carboxylate moieties on aluminum.
    Journal of Organometallic Chemistry - J ORGANOMET CHEM. 01/2011; 696(20):3155-3161.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The chronic use of glucocorticoids results in osteoporosis. Several sets of guidelines have been published on the management of glucocorticoid induced osteoporosis (GIO). These guidelines vary on their focus and highlight different aspects of the current concepts in the management of GIO. In this current article, we summarize recent guidelines for management of GIO and highlight similarities and differences as well as address some of the controversies generated by these guidelines.
    Current Osteoporosis Reports 10/2013;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute myelogenous leukemia (AML) largely affects older adults. Few interventions have sought to improve functional status and health-related quality of life (HRQL) during treatment. The objective of this study is to examine the feasibility of an exercise intervention among older adults with AML undergoing induction chemotherapy. Pilot study of adults ≥50 years of age hospitalized for AML chemotherapy. The four week exercise intervention included stretching, walking, and strength exercises. Feasibility measures included recruitment, retention, number of exercise sessions completed, and barriers to participation. Physical function, HRQL, depression, and distress were assessed at baseline (week 1), upon completion of intervention (week 5), and during follow-up (weeks 9-13). Exploratory analyses used repeated measures ANCOVA to model changes over time. Among 55 eligible inpatients, 24 enrolled (43.6%). Mean age was 65.1 years (SD 7.8). 87.5% of participants completed baseline measures; 70.8% attended ≥1 exercise sessions, and 50.0% completed post-intervention assessment. Among baseline characteristics, only higher physical performance was associated with greater number of exercise sessions attended (p=0.001). Post intervention, HRQL and depressive symptoms improved (p <0.05). Recruitment to an exercise intervention was feasible. Exercise shows promise to maintain physical function and enhance HRQL. Strategies to enhance adherence to exercise are needed to maximize benefit.
    Journal of Geriatric Oncology 01/2011; 2(1):11-17. · 1.12 Impact Factor